Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the PNPLA3 variant I148M.

Rausch V, Peccerella T, Lackner C, Yagmur E, Seitz HK, Longerich T, Mueller S.

World J Hepatol. 2016 Dec 18;8(35):1547-1556. doi: 10.4254/wjh.v8.i35.1547.

2.

How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?

Mann JP, Semple RK, Armstrong MJ.

Front Endocrinol (Lausanne). 2016 Nov 16;7:145. Review.

3.

SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy.

Kim KY, Jang HJ, Yang YR, Park KI, Seo J, Shin IW, Jeon TI, Ahn SC, Suh PG, Osborne TF, Seo YK.

Sci Rep. 2016 Oct 21;6:35732. doi: 10.1038/srep35732.

4.

TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.

Hsieh J, Koseki M, Molusky MM, Yakushiji E, Ichi I, Westerterp M, Iqbal J, Chan RB, Abramowicz S, Tascau L, Takiguchi S, Yamashita S, Welch CL, Di Paolo G, Hussain MM, Lefkowitch JH, Rader DJ, Tall AR.

Nature. 2016 Jul 14;535(7611):303-7. doi: 10.1038/nature18628.

5.

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.

Aragonès G, Auguet T, Armengol S, Berlanga A, Guiu-Jurado E, Aguilar C, Martínez S, Sabench F, Porras JA, Ruiz MD, Hernández M, Sirvent JJ, Del Castillo D, Richart C.

Int J Mol Sci. 2016 Apr 27;17(5). pii: E630. doi: 10.3390/ijms17050630.

6.

Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins.

Smagris E, Gilyard S, BasuRay S, Cohen JC, Hobbs HH.

J Biol Chem. 2016 May 13;291(20):10659-76. doi: 10.1074/jbc.M116.719955.

7.

Targeting Fat: Mechanisms of Protein Localization to Lipid Droplets.

Kory N, Farese RV Jr, Walther TC.

Trends Cell Biol. 2016 Jul;26(7):535-46. doi: 10.1016/j.tcb.2016.02.007. Review.

PMID:
26995697
8.

A Meta-Analysis of the Association Between the I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene and the Presence of Chronic Hepatitis C.

Zhang H, Xue L, Chen L, Jiang S, Xin Y, Xuan S.

Hepat Mon. 2015 Nov 28;15(11):e31987. doi: 10.5812/hepatmon.31987. Review.

9.

Alcoholic liver disease and hepatitis C virus infection.

Novo-Veleiro I, Alvela-Suárez L, Chamorro AJ, González-Sarmiento R, Laso FJ, Marcos M.

World J Gastroenterol. 2016 Jan 28;22(4):1411-20. doi: 10.3748/wjg.v22.i4.1411. Review.

10.

Genetic analysis of nonalcoholic fatty liver disease within a Caribbean-Hispanic population.

Edelman D, Kalia H, Delio M, Alani M, Krishnamurthy K, Abd M, Auton A, Wang T, Wolkoff AW, Morrow BE.

Mol Genet Genomic Med. 2015 Aug 11;3(6):558-69. doi: 10.1002/mgg3.168.

11.

A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.

Michaut A, Le Guillou D, Moreau C, Bucher S, McGill MR, Martinais S, Gicquel T, Morel I, Robin MA, Jaeschke H, Fromenty B.

Toxicol Appl Pharmacol. 2016 Feb 1;292:40-55. doi: 10.1016/j.taap.2015.12.020.

PMID:
26739624
12.

Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese.

Tang CS, Zhang H, Cheung CY, Xu M, Ho JC, Zhou W, Cherny SS, Zhang Y, Holmen O, Au KW, Yu H, Xu L, Jia J, Porsch RM, Sun L, Xu W, Zheng H, Wong LY, Mu Y, Dou J, Fong CH, Wang S, Hong X, Dong L, Liao Y, Wang J, Lam LS, Su X, Yan H, Yang ML, Chen J, Siu CW, Xie G, Woo YC, Wu Y, Tan KC, Hveem K, Cheung BM, Zöllner S, Xu A, Eugene Chen Y, Jiang CQ, Zhang Y, Lam TH, Ganesh SK, Huo Y, Sham PC, Lam KS, Willer CJ, Tse HF, Gao W.

Nat Commun. 2015 Dec 22;6:10206. doi: 10.1038/ncomms10206.

13.

Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.

Kahali B, Halligan B, Speliotes EK.

Semin Liver Dis. 2015 Nov;35(4):375-91. doi: 10.1055/s-0035-1567870. Review.

14.

Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk.

Li HG, Liu FF, Zhu HQ, Zhou X, Lu J, Chang H, Hu JH.

Medicine (Baltimore). 2015 Nov;94(47):e2019. doi: 10.1097/MD.0000000000002019.

15.

Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies.

Del Campo JA, Romero-Gómez M.

World J Gastroenterol. 2015 Oct 14;21(38):10776-82. doi: 10.3748/wjg.v21.i38.10776. Review.

16.

Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

Santoro N, Caprio S, Feldstein AE.

Clin Lipidol. 2013 Aug 1;8(4):411-418.

17.

Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.

Dongiovanni P, Romeo S, Valenti L.

Biomed Res Int. 2015;2015:460190. doi: 10.1155/2015/460190. Review.

18.

Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.

Oniki K, Saruwatari J, Izuka T, Kajiwara A, Morita K, Sakata M, Otake K, Ogata Y, Nakagawa K.

PLoS One. 2015 Jul 22;10(7):e0132640. doi: 10.1371/journal.pone.0132640.

19.

DAG tales: the multiple faces of diacylglycerol--stereochemistry, metabolism, and signaling.

Eichmann TO, Lass A.

Cell Mol Life Sci. 2015 Oct;72(20):3931-52. doi: 10.1007/s00018-015-1982-3. Review.

20.

PNPLA3 genetic variation in alcoholic steatosis and liver disease progression.

Stickel F, Hampe J, Trépo E, Datz C, Romeo S.

Hepatobiliary Surg Nutr. 2015 Jun;4(3):152-60. doi: 10.3978/j.issn.2304-3881.2014.11.04. Review.

Items per page

Supplemental Content

Support Center